INmune Bio, Inc.
NASDAQ:INMB
5.72 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||
Current Assets: | |||||||||
Cash & Cash Equivalents
| 35.848 | 52.153 | 74.81 | 21.967 | 6.996 | 0.186 | 1.371 | 0.142 | 0.012 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 35.848 | 52.153 | 74.81 | 21.967 | 6.996 | 0.186 | 1.371 | 0.142 | 0.012 |
Net Receivables
| 2.442 | 8.461 | 5.504 | 1.799 | 0.645 | 0.648 | 0.328 | 0.26 | 0 |
Inventory
| 0 | 0.034 | -5.504 | -2,018.619 | -769.129 | 0 | 0 | 0 | 0 |
Other Current Assets
| 1.652 | 4.061 | 2.292 | 0.22 | 0.124 | 0.016 | 0.043 | 0.003 | 0 |
Total Current Assets
| 39.942 | 64.675 | 82.606 | 23.986 | 7.765 | 0.849 | 1.899 | 0.452 | 0.012 |
Non-Current Assets: | |||||||||
Property, Plant & Equipment, Net
| 0.414 | 0.507 | 0.726 | 0.156 | 0.192 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 16.514 | 16.514 | 16.514 | 16.514 | 16.514 | 16.514 | 16.514 | 0 | 0 |
Goodwill and Intangible Assets
| 16.514 | 16.514 | 16.514 | 16.514 | 16.514 | 16.514 | 16.514 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.131 | 0.099 | 0.099 | 0 | -16.706 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 17.059 | 17.12 | 17.339 | 16.67 | 16.706 | 16.514 | 16.514 | 0 | 0 |
Total Assets
| 57.001 | 81.795 | 99.945 | 40.656 | 24.47 | 17.363 | 18.413 | 0.452 | 0.012 |
Liabilities & Equity: | |||||||||
Current Liabilities: | |||||||||
Account Payables
| 7.901 | 5.206 | 3.803 | 1.518 | 0.402 | 0.553 | 0.136 | 0.221 | 0.001 |
Short Term Debt
| 10.159 | 5.174 | 0.144 | 0.034 | 0.008 | 0 | 0 | 0.35 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0.489 | 0.616 | 0.474 | 0.191 | -692.091 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 0.405 | 0.538 | 0.412 | 0.224 | 0.29 | 0.271 | 0.173 | 0.03 | 0.03 |
Total Current Liabilities
| 18.465 | 10.918 | 4.359 | 1.776 | 0.7 | 0.824 | 0.31 | 0.601 | 0.031 |
Non-Current Liabilities: | |||||||||
Long Term Debt
| 0.397 | 10.223 | 15.162 | 0.126 | 0.16 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0.55 | 0.199 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0.397 | 10.773 | 15.361 | 0.126 | 0.16 | 0 | 0 | 0 | 0 |
Total Liabilities
| 18.862 | 21.691 | 19.72 | 1.903 | 0.861 | 0.824 | 0.31 | 0.601 | 0.031 |
Equity: | |||||||||
Preferred Stock
| 0.799 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.817 | 0.018 | 0.018 | 0.013 | 0.011 | 0.009 | 0.008 | 0.005 | 0.005 |
Retained Earnings
| -121.022 | -91.014 | -63.715 | -33.375 | -21.276 | -13.598 | -1.158 | -0.326 | -0.049 |
Accumulated Other Comprehensive Income/Loss
| -0.799 | -0.699 | 0.001 | 0.011 | -0.009 | 0.007 | 0.032 | -0.003 | 0 |
Other Total Stockholders Equity
| 159.143 | 151.799 | 143.921 | 72.104 | 44.834 | 25.446 | 19.171 | 0.175 | 0.025 |
Total Shareholders Equity
| 38.139 | 60.104 | 80.225 | 38.753 | 23.61 | 16.54 | 18.104 | -0.149 | -0.019 |
Total Equity
| 38.139 | 60.104 | 80.225 | 38.753 | 23.61 | 16.54 | 18.104 | -0.149 | -0.019 |
Total Liabilities & Shareholders Equity
| 57.001 | 81.795 | 99.945 | 40.656 | 24.47 | 17.363 | 18.413 | 0.452 | 0.012 |